Neo Ivy Capital Management purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 1,866 shares of the pharmaceutical company’s stock, valued at approximately $539,000. A number of other institutional investors and hedge funds have also recently modified their holdings of VRTX. Sequoia Financial […]
Northeast Financial Consultants Inc increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 3.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,123 shares of the pharmaceutical company’s stock after buying an additional 210 shares […]
Neuberger Berman Group LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 301,101 shares of the pharmaceutical company’s stock after acquiring an additional 35,292 shares during the […]
Northwest Bancshares Inc. decreased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 16.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,087 shares of the pharmaceutical company’s stock after selling 3,497 shares during the quarter. Vertex Pharmaceuticals […]
Princeton Capital Management LLC lessened its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 1.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,095 shares of the pharmaceutical company’s stock after selling 164 shares during the period. Vertex Pharmaceuticals comprises about 2.1% […]